Basics |
Revelation Biosciences, Inc.
|
IPO Date: |
November 18, 2020 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$4.4M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.11 | 5.71%
|
Avg Daily Range (30 D): |
$0.07 | 4.09%
|
Avg Daily Range (90 D): |
$0.11 | 4.67%
|
Institutional Daily Volume |
Avg Daily Volume: |
1.06M |
Avg Daily Volume (30 D): |
.31M |
Avg Daily Volume (90 D): |
.63M |
Trade Size |
Avg Trade Size (Sh.): |
271 |
Avg Trade Size (Sh.) (30 D): |
279 |
Avg Trade Size (Sh.) (90 D): |
180 |
Institutional Trades |
Total Inst.Trades: |
3 |
Avg Inst. Trade: |
$.84M |
Avg Inst. Trade (30 D): |
$M |
Avg Inst. Trade (90 D): |
$M |
Avg Inst. Trade Volume: |
.01M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$M |
Avg Closing Trade (30 D): |
$M |
Avg Closing Trade (90 D): |
$M |
Avg Closing Volume: |
K |
|
|
Financials |
|
TTM |
Q4 2024 |
FY 2024 |
Basic EPS
|
$-2.11
|
$-80.3
|
$-87.68
|
Diluted EPS
|
$-2.11
|
$-80.3
|
$-87.68
|
Revenue
|
$ M
|
$ M
|
$ M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -2.05M
|
$ -1.73M
|
$ -15.04M
|
Operating Income / Loss
|
$ -2.09M
|
$ -1.75M
|
$ -7.98M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -2.79M
|
$ -.04M
|
$ -5.49M
|
PE Ratio
|
|
|
|
Splits |
Jan 28, 2025:
1:16
|
Jan 25, 2024:
1:30
|
Feb 01, 2023:
1:35
|
|
|
|